FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4564711000001100: Rapamune 2mg tablets (Wyeth Laboratories) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17893701000001112 Rapamune 2mg tablets (Wyeth Laboratories) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
59570401000001117 Rapamune 2mg tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rapamune 2mg tablets (Wyeth Laboratories) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Is a Product containing precisely sirolimus 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Has active ingredient Sirolimus false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Has excipient Lactose false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Is a Rapamune true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Has specific active ingredient Sirolimus true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Is pack of False Rapamune 2mg tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) 100 tablet Is pack of False Rapamune 2mg tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has AMP True Rapamune 2mg tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Wyeth Laboratories) 100 tablet Has AMP True Rapamune 2mg tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start